Navigation Links
ALPCO Introduces a Mouse HMW and Total Adiponectin ELISA
Date:8/7/2009

SALEM, N.H., Aug. 7 /PRNewswire/ -- ALPCO Diagnostics has introduced a Mouse HMW Adiponectin ELISA kit that facilitates the testing process for this biomarker. This ELISA is unique; it is a departure from other methods for determining mouse HMW adiponectin and was first introduced in a pre-market form in a correspondence from Dr. Hiroyuki Ebinuma of the Tsukuba Research Institute in the journal Clinica Chimica Acta in February 2009.

Recently, an ELISA system was developed for the selective quantification of human adiponectin oligomers using protease pretreatment, and the Mouse HMW Adiponectin ELISA kit reflects a similar system for simultaneous detection of both high-molecular-weight (HMW) and total adiponectin. The human multimeric adiponectin ELISA from ALPCO and Sekisui has been cited in many publications, and is trusted by the research community worldwide for its consistency and quality. The new mouse HMW and total adiponectin ELISA has been held to the same exacting standards of quality in research, development and pre-market testing.

The Mouse HMW Adiponectin ELISA from ALPCO is differentiated from other ELISA methods on the market by simultaneously measuring both HMW and total adiponectin levels. Other available methods for measuring HMW adiponectin in mouse samples do not have a corresponding method for assessing total adiponectin available from the same manufacturer. Given the lack of an international reference standard for adiponectin, the determination of both HMW and total adiponectin using the same ELISA is preferable to eliminate this source of bias in the ratio.

The interest in animal models of insulin sensitivity in obese and pre-diabetic conditions continues to grow. Dr. Kelly Scribner Doering, Market Research Analyst with ALPCO, states, "Adiponectin is positively associated with insulin sensitivity and this kit is specifically designed for mouse samples so it aids preclinical research. This mouse HMW adiponectin ELISA would be of interest to both academic institutions and biotech companies."

Julie Rasku, a scientist with ALPCO Diagnostics' development team assures us, "I found the mouse adiponectin assay to be highly reproducible with low variance. It is a reliable method to determine mouse adiponectin levels." The Mouse HMW and Total Adiponectin ELISA kit provides a tremendous number of benefits and is truly one of a kind. ALPCO and Sekisui Medical Corporation are pleased to introduce this promising new research tool.

ALPCO was founded in 1990 as an importer and distributor of high quality research immunoassay kits. Since that time, their primary goals have been to offer a diverse line of assays that appeal to their broad customer base while also providing exceptional customer service and product support. In recent years, ALPCO has solidified its place in the market not only as a distributor but as a developer and manufacturer of immunoassays as well.

    CONTACT:
    Kate Kaplan
    800-592-5726


'/>"/>
SOURCE ALPCO Diagnostics
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Saint-Gobain Introduces Next Generation Silicone Tubing
2. Sanofi-aventis U.S. Introduces BenzaClin(R) Carekit
3. Aztech Controls Introduces Standardized Gas Sticks for Semiconductor Tool Hook Up
4. MUSA Technology Partners Introduces Linux/Open Source Service Desk
5. Caliper Life Sciences Introduces Staccato Protein Workstation for Automated Protein Sample Preparation & Analysis
6. Ganeden Biotech Introduces GanPro(TM) Direct-Fed Microbial for Livestock
7. METTLER TOLEDO Introduces an Affordable Reaction Block for Solid Phase Peptide Synthesis (SPPS)
8. Carbon Design Innovations, Inc. Introduces Carbon Nanotube Probe Technology for Atomic Force Microscopy, CNT-Probes Deliver New Level of AFM Imaging Performance
9. Oxford Performance Materials Introduces OXPEKK PermettaTM High Performance Polymer Films
10. Sigma-Aldrich Introduces New Services Network Complementing Its Life Sciences Product Portfolio
11. Waters Introduces New SYNAPT G2 with Greater Power, Versatility and Speed Than Any Other High-End Mass Spectrometer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... , February 8, 2016 ... Oncology Private Limited, an innovation-driven oncology company developing ... and less toxic, today announced that chairman emeritus ... has invested in the company as part of ... round, joining existing investors Navam Capital and Aarin ...
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... ... a wide range of loose, bulk foods at various stages of the production ... also used to inspect large bulk products post packaging such as sacks of ...
(Date:2/8/2016)... 2016 --> ... "Company"), the ultra-rapid Point-Of-Care (POC) molecular diagnostics company, today announces ... trachomatis (CT) test to be launched on the Company,s io® ... the CT test is now cleared for sale within the ... The launch of the io® CT test signals a new ...
(Date:2/5/2016)... SAN DIEGO , Feb. 5, 2016 ... the region,s trusted information source for community, health and ... San Diego) will integrate to enhance care coordination ... people to the services they need and to better ... to improve care.   San Diego ...
Breaking Biology Technology:
(Date:2/5/2016)... 5, 2016 http://www.researchandmarkets.com/research/5kvw8m/global_facial ... "Global Facial Recognition Market 2016-2020" ... http://www.researchandmarkets.com/research/5kvw8m/global_facial ) has announced the addition of ... report to their offering. --> ... has announced the addition of the ...
(Date:2/3/2016)... LIVERMORE, Calif. , Feb. 3, 2016 ... Police Department in Missouri ... of license plate reader (LPR) data from Vigilant Solutions. ... a hit-and-run case in which the victim was walking out ... a parking space next to his vehicle, striking his ...
(Date:2/2/2016)... 2016 Checkpoint Inhibitors for Cancer – ... Are you interested in the future of cancer ... inhibitors. Visiongain,s report gives those predictions to 2026 ... level. Avoid falling behind in data or ... revenues those emerging cancer therapies can achieve. There ...
Breaking Biology News(10 mins):